Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Julie A. McCarron"'
Autor:
Victor W. Pike, Julie A. McCarron, H. Umesha Shetty, Masanori Ichise, Christer Halldin, Håkan Wikström, Sami S. Zoghbi, Fumihiko Yasuno, E. S. Vermeulen, Robert B. Innis
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 34(10), 1670-1682. SPRINGER
Purpose We aimed to fulfill a need for a radioligand that may be simply labeled with carbon-11 for effective positron emission tomography (PET) imaging of brain 5-HT1A receptors.Methods Racemic RWAY (2,3,4,5,6,7-hexahydro-1-[4-[1-[4-(2-methoxyphenyl)
Autor:
Julie A. McCarron, Robert B. Innis, Jeih-San Liow, John L. Musachio, Jinsoo Hong, Sami S. Zoghbi, Victor W. Pike, Shuiyu Lu
Publikováno v:
Synapse. 61:96-105
Limited brain uptake of radioligands with otherwise optimal properties for imaging brain receptors can be improved by blocking the effect of P-glycoprotein (P-gp), an efflux pump at the blood-brain barrier. Using small animal positron emission tomogr
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 47:289-297
Reactions of no-carrier-added (NCA) [18F]β-fluoroethyl tosylate with amine, phenol or carboxylic acid to form the corresponding [18F]N-(β-fluoroethyl)amine, [18F]β-fluoroethyl ether or [18F]β-fluoroethyl ester, were found to be rapid (2–10 min)
Autor:
Julie A. McCarron, Victor W. Pike
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 46:1127-1140
Three methods are described for labeling methanesulfonyl (mesyl) chloride with no-carrier-added (NCA) carbon-11 (t1/2=20.4 min; β+=99.8%) to provide a new labeling agent of potential value in radiopharmaceutical development for positron emission tom
Autor:
S Marchais, Julie A. McCarron, Lars Farde, Håkan Wikström, Susan P. Hume, Maria Constantinou, Safiye Osman, Victor W. Pike, Bengt Andrée, Bartek Nowicki, Carl-Gunnar Swahn, Christer Halldin, Johan Sandell
Publikováno v:
Nuclear Medicine and Biology. 27:449-455
ABSTRACT. [ Carbonyl - 11 C]WAY-100635 (WAY) has proved to be a very useful radioligand for the imaging of brain 5-HT 1A receptors in human brain in vivo with positron emission tomography (PET). WAY is now being applied widely for clinical research a
Autor:
Nathalie Ginovart, Hiroshi Ito, Christer Halldin, Julie A. McCarron, Lars Farde, Victor W. Pike, Camilla Lundkvist
Publikováno v:
Psychopharmacology. 133:196-202
[carbonyl-11C]WAY-100635 is a new radioligand which can be used with positron emission tomography (PET) to provide high contrast delineation of human brain regions that are rich in 5-HT1A receptors. In the present PET study, the binding of [carbonyl-
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 38:941-953
WAY-100635 [N-(2-(1-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl))-N-(2-pyridyl)-cyclohexanecarboxamide], when labelled in its carbonyl position with carbon-11 (t 1/2 = 20.4 min), is an effective radioligand for the study of 5-HT 1A receptors in human br
Autor:
Julie A. McCarron, Victor W. Pike, Christer Halldin, Carl-Gunnar Swahn, Ian Anthony Cliffe, Paul M. Grasby, Camilla Lundkvist, Sajinder K. Luthra, Tjeerd Barf, Håkan Wikström, Safiye Osman, Allan Fletcher, Christopher J. Bench, Lars Farde, Natalie Ginovart
Publikováno v:
Nuclear Medicine and Biology. 23:627-634
N-(2-(4-(2-Methoxy-phenyl)-1-piperazin-1-yl)ethyl)-N-(2-pyridyl) cyclohexanecarboxamide (WAY-100635), labelled in the O-methyl group with carbon-11 (t1/2 = 20.4 min), is a promising radioligand for application with positron emission tomography (PET)
Autor:
Håkan Wikström, S Marchais, Christer Halldin, Johan Sandell, Balasz Gulyas, Lars Farde, Zsolt Cselényi, Judit Sovago, Victor W. Pike, Julie A. McCarron
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 44:S167-S169
Autor:
Victor W. Pike, Sami S. Zoghbi, Fumihiko Yasuno, Jeih-San Liow, Julie A. McCarron, Xiang-Yang Zhang, Robert B. Innis, Jinsoo Hong
Publikováno v:
Synapse (New York, N.Y.). 61(7)
C)(R)-(� )-RWAY has been shown to be a promising radioligand for imaging brain 5-HT1A receptors with positron emission tomography in rodents and nonhuman primates. We now report the first use of ( 11 C)(R)-(� )-RWAY in six healthy human subjects,